Cannabinoid acids

Cannabichromenic acid

A chromenol that is 2<em>H</em>-chromene substituted by methyl, 2-methylpent-2-en-5-yl, hydroxy, carboxy and pentyl groups at positions 2,2,5,6 and 7, respectively.

Definition: CHEBI:167557 · Chemical Entities of Biological Interest · release 253

23public articles

2registered condition areas

All documents →

Identity & provenance

Chemical identity

C22H30O4 · molecular weight 358.478

Sources: ChEBI · 253

0 referenced plant-occurrence records. They are identity candidates, not clinical evidence.

Research areas

Conditions found alongside this compound

Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.

Epilepsy and cannabinoids

3 matching public articles

Candidate association · not a treatment claim

Parkinson disease and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Linked local records

Medicines and registered studies

Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.

Medicines with this active ingredient

No public medicine record matched.

Registered studies

0 exact source-intervention matches.

No registered study intervention matched.

Recent research

2026

Therapeutic potential of acidic cannabinoids: an update.

Journal of Cannabis Research · Free full text

2026

X-ray crystal structures of the cannabinoid synthases CBCAS, CBDAS and THCAS.

Current Research in Structural Biology · Free full text

2026

Resurrected Ancestral Cannabis Enzymes Unveil the Origin and Functional Evolution of Cannabinoid Synthases.

Plant Biotechnology Journal · Free full text

2026

Physiological effect and pharmacokinetic evaluation of combined oral administration of cannabidiolic acid and cannabigerolic acid in dogs.

Frontiers in Veterinary Science · Free full text

2025

Pharmacokinetics of Non-Psychotropic Phytocannabinoids.

Pharmaceutics · Free full text

2025

Elevated relative humidity significantly decreases cannabinoid concentrations while delaying flowering development in Cannabis sativa L.

Frontiers in Plant Science · Free full text

2025-10-07

Structural and biochemical basis for cannabinoid cyclase activity in marine bacterial flavoenzymes

bioRxiv · Free full text

Cannabichromenic acid

Chemical identity

Conditions found alongside this compound

Epilepsy and cannabinoids

Parkinson disease and cannabinoids

Medicines and registered studies

Medicines with this active ingredient

Registered studies

Recent research

Therapeutic potential of acidic cannabinoids: an update.

X-ray crystal structures of the cannabinoid synthases CBCAS, CBDAS and THCAS.

Resurrected Ancestral Cannabis Enzymes Unveil the Origin and Functional Evolution of Cannabinoid Synthases.

Physiological effect and pharmacokinetic evaluation of combined oral administration of cannabidiolic acid and cannabigerolic acid in dogs.

Pharmacokinetics of Non-Psychotropic Phytocannabinoids.

Elevated relative humidity significantly decreases cannabinoid concentrations while delaying flowering development in Cannabis sativa L.

Structural and biochemical basis for cannabinoid cyclase activity in marine bacterial flavoenzymes

Comparison of decarboxylation rates of acidic cannabinoids between secretory cavity contents and air-dried inflorescence extracts in Cannabis sativa cv. 'Cherry Wine'.

Genome-wide identification of cannabinoid biosynthesis genes in non-drug type Cannabis (Cannabis sativa L.) cultivar.

Chiral Separation of Cannabichromene, Cannabicyclol, and Their Acidic Analogs on Polysaccharide Chiral Stationary Phases.

Natural Cannabichromene (CBC) Shows Distinct Scalemicity Grades and Enantiomeric Dominance in Cannabis sativa Strains.

Investigation of the Effect of the Auxin Antagonist PEO-IAA on Cannabinoid Gene Expression and Content in Cannabis sativa L. Plants under In Vitro Conditions.